Dr. Andrew Cowan, MD
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
9 reported clinical trials
14 drugs studied
Area of expertise
1Multiple Myeloma
Stage IV
Stage III
2Plasma Cell Neoplasm
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Andrew Cowan, MD is currently running
Quadruple Therapy
for Multiple Myeloma
This phase II trial studies the effect of isatuximab, carfilzomib, pomalidomide, and dexamethasone in treating patients with multiple myeloma that has come back (relapsed) or does not respond to treatment (refractory). Isatuximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Carfilzomib may stop the growth of cancer cells by blocking some of the proteins needed for cell growth. Pomalidomide may help shrink or slow the growth of mutliple myeloma. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Giving isatuximab, carfilzomib, pomalidomide, and dexamethasone may kill more cancer cells.
Recruiting1 award Phase 221 criteria
Mezigdomide Combo vs. Pomalidomide Combo
for Multiple Myeloma
This trial is testing two drug combinations to find out which one is better and safer for patients with multiple myeloma that has come back or not responded to previous treatments. The drugs work together to kill cancer cells by stopping their growth, helping the immune system attack them, and making it harder for them to survive.
Recruiting2 awards Phase 3
More about Andrew Cowan, MD
Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Andrew Cowan, MD has experience with
- Dexamethasone
- Pomalidomide
- Lenalidomide
- High Throughput Screening
- Nivolumab
- Carfilzomib
Breakdown of trials Andrew Cowan, MD has run
Multiple Myeloma
Plasma Cell Neoplasm
Childhood Cancer
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Cowan, MD specialize in?
Andrew Cowan, MD focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved Stage IV patients, or patients who are Stage III.
Is Andrew Cowan, MD currently recruiting for clinical trials?
Yes, Andrew Cowan, MD is currently recruiting for 5 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Andrew Cowan, MD has studied deeply?
Yes, Andrew Cowan, MD has studied treatments such as Dexamethasone, Pomalidomide, Lenalidomide.
What is the best way to schedule an appointment with Andrew Cowan, MD?
Apply for one of the trials that Andrew Cowan, MD is conducting.
What is the office address of Andrew Cowan, MD?
The office of Andrew Cowan, MD is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.